DK1018341T3 - Antistressmidler og funktionelle födevarer - Google Patents

Antistressmidler og funktionelle födevarer

Info

Publication number
DK1018341T3
DK1018341T3 DK98901519T DK98901519T DK1018341T3 DK 1018341 T3 DK1018341 T3 DK 1018341T3 DK 98901519 T DK98901519 T DK 98901519T DK 98901519 T DK98901519 T DK 98901519T DK 1018341 T3 DK1018341 T3 DK 1018341T3
Authority
DK
Denmark
Prior art keywords
pro
functional foods
agents
stress agents
antistress
Prior art date
Application number
DK98901519T
Other languages
Danish (da)
English (en)
Inventor
Akihiro Masuyama
Toshiaki Takano
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Application granted granted Critical
Publication of DK1018341T3 publication Critical patent/DK1018341T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Confectionery (AREA)
  • Peptides Or Proteins (AREA)
DK98901519T 1997-09-26 1998-02-05 Antistressmidler og funktionelle födevarer DK1018341T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26242297A JP4727770B2 (ja) 1997-09-26 1997-09-26 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
PCT/JP1998/000480 WO1999016461A1 (fr) 1997-09-26 1998-02-05 Agents antistress et aliments fonctionnels

Publications (1)

Publication Number Publication Date
DK1018341T3 true DK1018341T3 (da) 2004-07-26

Family

ID=17375571

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98901519T DK1018341T3 (da) 1997-09-26 1998-02-05 Antistressmidler og funktionelle födevarer

Country Status (23)

Country Link
US (1) US6410685B1 (cs)
EP (1) EP1018341B1 (cs)
JP (1) JP4727770B2 (cs)
KR (2) KR100383492B1 (cs)
CN (1) CN1198641C (cs)
AT (1) ATE264687T1 (cs)
AU (1) AU728565B2 (cs)
BG (1) BG64692B1 (cs)
BR (1) BR9813222A (cs)
CA (1) CA2303810C (cs)
CZ (1) CZ298848B6 (cs)
DE (1) DE69823369T2 (cs)
DK (1) DK1018341T3 (cs)
ES (1) ES2219868T3 (cs)
HU (1) HUP0004617A3 (cs)
ID (1) ID25635A (cs)
IN (1) IN190794B (cs)
PL (1) PL192873B1 (cs)
PT (1) PT1018341E (cs)
SK (1) SK285148B6 (cs)
TR (1) TR200000863T2 (cs)
TW (1) TWI231213B (cs)
WO (1) WO1999016461A1 (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
WO2003102195A1 (en) 2002-06-04 2003-12-11 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
WO2004026296A1 (ja) * 2002-09-18 2004-04-01 Ajinomoto Co., Inc. 抗ストレス性疾患組成物
US20050222263A1 (en) * 2002-09-18 2005-10-06 Ajinomoto Co., Inc. Compositions against stress-related diseases and methods for treating stress-related diseases
TWI344371B (en) * 2003-03-18 2011-07-01 Suntory Holdings Ltd Angiotensin-converting enzyme inhibitory peptides
AU2004237455B2 (en) * 2003-05-05 2007-08-02 Dsm Ip Assets B.V. Hydrolysed casein product comprising tripeptides IPP and/ or VPP
EP1727440A1 (en) * 2004-03-19 2006-12-06 Campina Nederland Holding B.V. Method of preparing a food ingredient and food product having angiotensin-i-converting enzyme inhibiting properties and products thus obtained
EP1774014A2 (en) * 2004-07-12 2007-04-18 DSMIP Assets B.V. Blood pressure lowering oligopeptides
CN103463615B (zh) * 2005-02-24 2016-09-07 帝斯曼知识产权资产管理有限公司 来自糖巨肽的血压降低肽
BRPI0613979A2 (pt) * 2005-07-26 2011-02-22 Calpis Co Ltd processo para a produção de leite fermentado e bebida/alimento feito a partir de leite fermentado
WO2007079977A2 (en) * 2006-01-16 2007-07-19 Dsm Ip Assets B.V. Nutraceutical compositions comprising tripeptides
CN101443031A (zh) * 2006-05-15 2009-05-27 瓦利奥有限公司 治疗用肽的新应用
RU2304444C1 (ru) * 2006-05-23 2007-08-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения
JP5394628B2 (ja) * 2007-02-09 2014-01-22 クロスフィールドバイオ株式会社 新規なラクトバチルス属微生物および乳酸菌製剤
CN101909645A (zh) * 2007-11-14 2010-12-08 帝斯曼知识产权资产管理有限公司 包含ipp和/或vpp的降血压组合
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2011136932A (ja) 2009-12-28 2011-07-14 Calpis Co Ltd 脳機能改善用組成物および脳機能を改善する方法
JP2010183918A (ja) * 2010-06-01 2010-08-26 Calpis Co Ltd トリペプチドの製造方法
CN102399261B (zh) * 2010-09-07 2014-06-25 任发政 具有血管紧张素转化酶c-端选择性抑制活性的三肽及其应用和组合物
JP2011102331A (ja) * 2011-02-17 2011-05-26 Calpis Co Ltd 尿中ドーパミン低下の予防及び軽減剤
JP5892687B2 (ja) 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103204909B (zh) * 2013-04-17 2014-09-03 苏州凯祥生物科技有限公司 一种抗高血压活性肽vppipp
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2014208702A (ja) * 2014-07-31 2014-11-06 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
CN104725485B (zh) * 2014-11-19 2018-01-16 扬州大学 一种重组活性肽及其同步制备方法
JPWO2017057319A1 (ja) * 2015-09-30 2018-07-19 株式会社明治 乳酸菌スターターの調製方法及び発酵乳の製造方法
CN111909978B (zh) * 2020-07-10 2021-06-22 青岛农业大学 一种利用发酵法从玉米蛋白粉中定向制备富含lpp水解物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189064A (en) * 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
ES2077021T3 (es) * 1989-02-16 1995-11-16 Sankyo Co Peptidos que tienen actividad inhibidora de renina, su preparacion y uso.
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US5604198A (en) * 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
JPH08275752A (ja) * 1995-04-07 1996-10-22 Riken Vitamin Co Ltd ストレス改善食品
JPH0920660A (ja) * 1995-07-04 1997-01-21 Suntory Ltd 抗ストレス組成物
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤

Also Published As

Publication number Publication date
PL339348A1 (en) 2000-12-18
DE69823369T2 (de) 2005-05-04
BG64692B1 (bg) 2005-12-30
EP1018341B1 (en) 2004-04-21
AU728565B2 (en) 2001-01-11
ATE264687T1 (de) 2004-05-15
TWI231213B (en) 2005-04-21
CN1198641C (zh) 2005-04-27
US6410685B1 (en) 2002-06-25
CN1279614A (zh) 2001-01-10
TR200000863T2 (tr) 2000-11-21
PL192873B1 (pl) 2006-12-29
SK4362000A3 (en) 2001-03-12
KR20030005137A (ko) 2003-01-15
JP4727770B2 (ja) 2011-07-20
ES2219868T3 (es) 2004-12-01
DE69823369D1 (de) 2004-05-27
KR100379819B1 (ko) 2003-04-14
ID25635A (id) 2000-10-19
CZ20001083A3 (cs) 2001-01-17
CZ298848B6 (cs) 2008-02-27
WO1999016461A1 (fr) 1999-04-08
SK285148B6 (sk) 2006-07-07
EP1018341A1 (en) 2000-07-12
HUP0004617A2 (hu) 2001-05-28
CA2303810A1 (en) 1999-04-08
PT1018341E (pt) 2004-08-31
CA2303810C (en) 2007-03-27
EP1018341A4 (en) 2002-08-28
AU5780198A (en) 1999-04-23
IN190794B (cs) 2003-08-23
KR20010024277A (ko) 2001-03-26
BR9813222A (pt) 2000-08-29
KR100383492B1 (ko) 2003-05-12
JPH11100328A (ja) 1999-04-13
HUP0004617A3 (en) 2001-11-28
BG104381A (en) 2001-02-28

Similar Documents

Publication Publication Date Title
DK1018341T3 (da) Antistressmidler og funktionelle födevarer
CA2223510A1 (en) Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
ATE148469T1 (de) Zyklosporine
BR9507752A (pt) Cepas de lactobacilos de origem humanan suas composições e seus usos
WO2003051313A3 (en) Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
DE60119784D1 (de) Cyclische salen metall verbindungen als einfänger von sauerstoffradikalen und verwendbar als antioxidantien bei der behandlung und vorbeugung von krankheiten
GB2288732B (en) Pharmaceutical compositions
MY124559A (en) Anti-stress agent and functional food having anti-stress effect
IT1312377B1 (it) Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
WO1998033491A3 (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
TR200003736T2 (tr) Anksiyete durumlarına ya da depresyona bağlı değişikliklerin önlenmesi
WO2003013549A3 (de) Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern
NZ505742A (en) Compositions containing aminobiguanides with antimicrobial activity used to treat contact lenses
NO970533D0 (no) Blodbehandlingssystem og fremgangsmåte som overvåker citratretur til giveren
WO2005007137A8 (de) Ambroxolhaltige tabletten
NO20006646D0 (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
FR2717548B1 (fr) Dispositif tendeur de goujons, notamment pour le boulonnage de couvercles et en particulier de cuves sous pression de réacteurs.
NO20001196L (no) Nootropisk middel
DE69902879D1 (de) Pflanzliches antivirales mittel
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
WO1997005864A3 (en) Use of l-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs
ATE114311T1 (de) Bivalente liganden, wirksam für die blockierung des enzyms acat.
TR200002939T2 (tr) Paroksetin maleat
HK1045103A1 (zh) Bpi蛋白質產品於bpi蛋白質不足的人體的治療用途
RU2000104127A (ru) Штамм bacillus subtilis x-15, используемый для профилактики и лечения эндометритов у коров